Trials / Recruiting
RecruitingNCT05522972
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
Improving Normal and Amblyopic Vision With Video Games and Perceptual Learning
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Nova Southeastern University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.
Detailed description
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. Our previous findings (see Publications) show that the adult amblyopic brain is still plastic and malleable, suggesting that active approach is potential useful in treating amblyopia.The goal of this project is to assess the limits and mechanisms of neural plasticity in both normal and amblyopic spatial vision. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia. Research participants will be asked to practice a visual discrimination task (perceptual learning) or to play video games with the amblyopic eye for a period of time. A range of visual functions will be monitored during the course of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Video Game Vision Training | A new approach for improving amblyopic vision using video games |
| BEHAVIORAL | Perceptual Learning | A new approach for improving amblyopic vision with perceptual learning |
| BEHAVIORAL | Occlusion Therapy | Conventional treatment for amblyopia |
Timeline
- Start date
- 2022-09-13
- Primary completion
- 2029-08-31
- Completion
- 2029-08-31
- First posted
- 2022-08-31
- Last updated
- 2025-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05522972. Inclusion in this directory is not an endorsement.